INTERSPINOUS SPACERS MARKET ANALYSIS

Market Challenges And Opportunities

Interspinous Spacers Market – Drivers

Increasing product approvals from regulatory bodies is expected to drive the interspinous spacers market growth during the forecast period. For instance, in 2015, the U.S. Food and Drug Administration (FDA) approved Superion InterSpinous Spacer of VertiFlex Inc., VertiFlex Inc. is developer of advanced minimally invasive interventions for spinal stenosis.

Moreover, favorable reimbursement policies is also expected to drive the interspinous spacers market growth during the forecast period. For instance, in 2018, Paradigm Spine, a company specializing in the treatment of lumbar spinal stenosis, announced the issuance of a broad coverage medical policy from BlueCross BlueShield covering its coflex device for the surgical treatment of lumbar spinal stenosis.

Interspinous Spacers Market –Restraints

However, complications associated with lumbar spinal fusion in older patients with spinal stenosis is a major factor restraining the interspinous spacers market growth. For instance, according to the American Association of Neurological Surgeons’ study on complication associated with lumbar spinal stenosis in 2014, 1 in every 6 elderly patients treated with lumbar spinal stenosis underwent reoperation on the spine within two years of surgery and nearly 1 in every 4 patients was readmitted for a surgery-related complication in the US.